Cargando…

Sphingolipid metabolism and signaling in cardiovascular diseases

Sphingolipids are a structural component of the cell membrane, derived from sphingosine, an amino alcohol. Its sphingoid base undergoes various types of enzymatic transformations that lead to the formation of biologically active compounds, which play a crucial role in the essential pathways of cellu...

Descripción completa

Detalles Bibliográficos
Autores principales: Borodzicz-Jażdżyk, Sonia, Jażdżyk, Piotr, Łysik, Wojciech, Cudnoch-Jȩdrzejewska, Agnieszka, Czarzasta, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471951/
https://www.ncbi.nlm.nih.gov/pubmed/36119733
http://dx.doi.org/10.3389/fcvm.2022.915961
_version_ 1784789198239170560
author Borodzicz-Jażdżyk, Sonia
Jażdżyk, Piotr
Łysik, Wojciech
Cudnoch-Jȩdrzejewska, Agnieszka
Czarzasta, Katarzyna
author_facet Borodzicz-Jażdżyk, Sonia
Jażdżyk, Piotr
Łysik, Wojciech
Cudnoch-Jȩdrzejewska, Agnieszka
Czarzasta, Katarzyna
author_sort Borodzicz-Jażdżyk, Sonia
collection PubMed
description Sphingolipids are a structural component of the cell membrane, derived from sphingosine, an amino alcohol. Its sphingoid base undergoes various types of enzymatic transformations that lead to the formation of biologically active compounds, which play a crucial role in the essential pathways of cellular signaling, proliferation, maturation, and death. The constantly growing number of experimental and clinical studies emphasizes the pivotal role of sphingolipids in the pathophysiology of cardiovascular diseases, including, in particular, ischemic heart disease, hypertension, heart failure, and stroke. It has also been proven that altering the sphingolipid metabolism has cardioprotective properties in cardiac pathologies, including myocardial infarction. Recent studies suggest that selected sphingolipids may serve as valuable biomarkers useful in the prognosis of cardiovascular disorders in clinical practice. This review aims to provide an overview of the current knowledge of sphingolipid metabolism and signaling in cardiovascular diseases.
format Online
Article
Text
id pubmed-9471951
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94719512022-09-15 Sphingolipid metabolism and signaling in cardiovascular diseases Borodzicz-Jażdżyk, Sonia Jażdżyk, Piotr Łysik, Wojciech Cudnoch-Jȩdrzejewska, Agnieszka Czarzasta, Katarzyna Front Cardiovasc Med Cardiovascular Medicine Sphingolipids are a structural component of the cell membrane, derived from sphingosine, an amino alcohol. Its sphingoid base undergoes various types of enzymatic transformations that lead to the formation of biologically active compounds, which play a crucial role in the essential pathways of cellular signaling, proliferation, maturation, and death. The constantly growing number of experimental and clinical studies emphasizes the pivotal role of sphingolipids in the pathophysiology of cardiovascular diseases, including, in particular, ischemic heart disease, hypertension, heart failure, and stroke. It has also been proven that altering the sphingolipid metabolism has cardioprotective properties in cardiac pathologies, including myocardial infarction. Recent studies suggest that selected sphingolipids may serve as valuable biomarkers useful in the prognosis of cardiovascular disorders in clinical practice. This review aims to provide an overview of the current knowledge of sphingolipid metabolism and signaling in cardiovascular diseases. Frontiers Media S.A. 2022-08-31 /pmc/articles/PMC9471951/ /pubmed/36119733 http://dx.doi.org/10.3389/fcvm.2022.915961 Text en Copyright © 2022 Borodzicz-Jażdżyk, Jażdżyk, Łysik, Cudnoch-Jȩdrzejewska and Czarzasta. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Borodzicz-Jażdżyk, Sonia
Jażdżyk, Piotr
Łysik, Wojciech
Cudnoch-Jȩdrzejewska, Agnieszka
Czarzasta, Katarzyna
Sphingolipid metabolism and signaling in cardiovascular diseases
title Sphingolipid metabolism and signaling in cardiovascular diseases
title_full Sphingolipid metabolism and signaling in cardiovascular diseases
title_fullStr Sphingolipid metabolism and signaling in cardiovascular diseases
title_full_unstemmed Sphingolipid metabolism and signaling in cardiovascular diseases
title_short Sphingolipid metabolism and signaling in cardiovascular diseases
title_sort sphingolipid metabolism and signaling in cardiovascular diseases
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471951/
https://www.ncbi.nlm.nih.gov/pubmed/36119733
http://dx.doi.org/10.3389/fcvm.2022.915961
work_keys_str_mv AT borodziczjazdzyksonia sphingolipidmetabolismandsignalingincardiovasculardiseases
AT jazdzykpiotr sphingolipidmetabolismandsignalingincardiovasculardiseases
AT łysikwojciech sphingolipidmetabolismandsignalingincardiovasculardiseases
AT cudnochjedrzejewskaagnieszka sphingolipidmetabolismandsignalingincardiovasculardiseases
AT czarzastakatarzyna sphingolipidmetabolismandsignalingincardiovasculardiseases